Generated by GPT-5-mini| Inpatient Prospective Payment System | |
|---|---|
| Name | Inpatient Prospective Payment System |
| Country | United States |
| Introduced | 1983 |
| Administered by | Centers for Medicare & Medicaid Services |
| Type | Healthcare payment system |
Inpatient Prospective Payment System The Inpatient Prospective Payment System is a United States federal payment mechanism that reimburses acute care hospitals for inpatient stays under a fixed, case-based schedule. Originating from legislative reform in the 1980s, it aligns hospital payments with coded clinical categories and prospective rates set by the Centers for Medicare & Medicaid Services, shaping relations among hospitals, insurers, and clinical practice patterns. The system interacts with federal statutes, regulatory agencies, academic research, and hospital administration across national healthcare delivery networks.
The system was created following passage of the Social Security Amendments of 1983, implemented by the Health Care Financing Administration and later administered by the Centers for Medicare & Medicaid Services, and it operates within the statutory framework of the Social Security Act. It established a prospective, diagnosis-driven payment approach that replaced historical cost-based reimbursement used by institutions including Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, and Veterans Affairs medical centers. Major stakeholders include the American Hospital Association, American Medical Association, state health departments, private insurers such as Blue Cross Blue Shield Association and UnitedHealthcare, and hospital quality organizations like The Joint Commission and National Quality Forum.
Payments under the system combine several elements: a base payment per classified case, geographic adjustments from the Hospital Wage Index influenced by metropolitan labor markets like New York City and Los Angeles, policy adjustments from the Medicare Payment Advisory Commission, and outlier payments for high-cost cases. The methodology uses payment rate setting informed by claims data from the Medicare Provider Analysis and Review dataset and rulemaking processes published in the Federal Register. Components also include capital payments, indirect medical education adjustments affecting teaching hospitals such as Harvard Medical School–affiliated centers, and disproportionate share hospital adjustments impacting safety-net institutions like Cook County Hospital.
Central to the payment model are Diagnosis-Related Groups derived from clinical classification systems developed by entities including Yale University researchers and later refined through collaborations with the Centers for Disease Control and Prevention. DRGs group cases by principal diagnosis, procedures, comorbidities, and discharge status; subsequent refinements produced Medicare Severity DRGs (MS-DRGs). Classification work draws on standards from the World Health Organization's International Statistical Classification of Diseases and Related Health Problems and procedural coding systems used by the American Medical Association and Centers for Medicare & Medicaid Services contractors. The grouper logic and weight-setting processes have been evaluated in studies by researchers at Johns Hopkins Bloomberg School of Public Health and policy analyses from the Kaiser Family Foundation.
Implementation occurs through annual rulemaking by the Centers for Medicare & Medicaid Services with input from advisory bodies such as the Medicare Payment Advisory Commission and stakeholders including the American Hospital Association and state hospital associations. Major updates have resulted from statutes like the Balanced Budget Act of 1997, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, and the Patient Protection and Affordable Care Act. Rule changes are debated in forums including congressional hearings before the United States House Committee on Ways and Means and the United States Senate Committee on Finance, with technical modeling from agencies like the Office of Management and Budget and research from think tanks such as the Brookings Institution and Urban Institute.
The system incentivized hospitals—ranging from large academic centers like Massachusetts General Hospital to community hospitals in regions like Rural Health Clinics—to increase efficiency and reduce length of stay, influencing clinical pathways studied in trials at institutions such as Brigham and Women's Hospital. Payment predictability affected capital planning, investments in care coordination programs like those promoted by Institute for Healthcare Improvement, and adoption of case management and utilization review practices. Evaluations by Centers for Medicare & Medicaid Services analysts, academic groups at Stanford University and University of Pennsylvania, and policy outlets such as Health Affairs measured changes in readmission rates, mortality trends, and cost shifting to private payers including Aetna and Cigna.
Critics including scholars at Harvard School of Public Health and advocacy groups like Families USA have pointed to potential unintended effects such as upcoding, patient selection, and impacts on complex care. Legal and policy challenges have been raised in contexts involving the Department of Health and Human Services and litigation supported by the American Hospital Association. Reforms have sought to address quality incentives through programs like the Hospital Readmissions Reduction Program, value-based purchasing initiatives, and bundled payment pilots spearheaded by the Center for Medicare and Medicaid Innovation. Ongoing debates engage policymakers in venues such as the Commonwealth Fund, professional societies including the Association of American Medical Colleges, and international comparisons to payment reforms in systems like the National Health Service.
Category:Medicare payment systems